• Monomethyl Auristatin E: A State-Aware ADC Payload

  2026-08-17

  Monomethyl auristatin E (MMAE) is more than a potent ADC cytotoxin: its performance depends on target delivery, intracellular release, and tumor-cell state. This article connects MMAE assay design with cancer plasticity biology while defining practical controls and translational limits.

• IgSF6 Deficiency Reprograms Macrophage Antibacterial Defense

  2026-08-16

  The reference study identifies endoplasmic reticulum-localized IgSF6 as a regulator of IRE1α/XBP1 signaling, reactive oxygen species, and antibacterial activity in intestinal macrophages. Its findings reveal a context-dependent tradeoff: IgSF6 loss improves resistance to Salmonella infection but increases susceptibility to chemically induced colitis, linking antimicrobial defense to intestinal tissue homeostasis.

• Clarithromycin and CYP3A: A Translational Playbook

  2026-08-15

  A mechanism-first guide to using Clarithromycin as a CYP3A inhibitor in drug-drug interaction research, with practical assay design, translational context, and strategic lessons from dabigatran pharmacokinetics.

• Firefly Luciferase mRNA Delivery and Assay Guide

  2026-08-14

  Build sensitive reporter assays with Cap1-capped, 5-moUTP modified mRNA engineered for sustained firefly luciferase expression. This guide connects transcript handling, carrier selection, quantitative workflows, and troubleshooting for cell-based delivery, translation studies, viability assays, and exploratory imaging.

• Merbromin: From Antiseptic Evidence to Assay Design

  2026-08-14

  Merbromin is more than a historical antiseptic: it is a protein–ligand interaction probe and biochemical research fluorescent dye for mechanistic assay development. This article connects clinical evidence standards with fluorescence, enzyme inhibition, antimicrobial, and antiviral workflow decisions.

• Neuroligin 1 Proteolysis Sustains Social Memory

  2026-08-13

  Liu et al. show that social interaction triggers secretase-dependent Neuroligin 1 processing in the ventral hippocampus, producing an intracellular fragment that supports synaptic remodeling and social memory maintenance. The study identifies a mechanistic link between extracellular proteolysis, cofilin signaling, dendritic spine maturation, and the persistence of recently acquired memories.

• Rational Copper Ionophores for Cuproptosis

  2026-08-13

  This study shows that simple n-alkyl-chain tuning can convert a Schiff base derivative into an effective copper ionophore, with C6 providing the most favorable balance of copper affinity, lipophilicity, and intracellular transport. Its activity against triple-negative breast cancer models links copper delivery to reactive oxygen species accumulation, mitochondrial dysfunction, cuproptosis, and immune-related antitumor effects.

• AZD3463: ALK/IGF1R Inhibitor for Neuroblastoma

  2026-08-12

  AZD3463 is a preclinical ALK/IGF1R inhibitor that targets ALK signaling, including the PI3K/AKT/mTOR axis, in neuroblastoma models. Product information reports activity against wild-type ALK and activating F1174L and D1091N variants, with tumor-growth suppression at 15 mg/kg by intraperitoneal administration in orthotopic mouse xenografts.

• Melittin B6628 for Reliable Cell Assays

  2026-08-12

  Learn how Melittin, SKU B6628, can support controlled studies of cell viability, GPCR signaling, apoptosis, and cancer biology. This scenario-based guide connects product handling data with glioblastoma signaling evidence while clearly separating established findings from practical assay recommendations.

• Caspase-3 Colorimetric Assay Kit for Immune Studies

  2026-08-11

  Use K2008 to quantify DEVD-dependent caspase-3 activity alongside inflammatory and ER-stress readouts in macrophage models. This workflow connects a rapid apoptosis assay to mechanistic studies without mistaking bulk caspase signal for proof of cell death or a specific upstream pathway.

• Concanamycin A: V-ATPase Workflows

  2026-08-11

  Concanamycin A provides a rapid pharmacological route to test how V-ATPase-dependent acidification controls trafficking, autophagy, apoptosis, and invasion. This workflow-centered guide shows how to use its nanomolar activity without confusing blocked degradation with increased autophagy or mistaking vehicle effects for cancer-cell phenotypes.

• α2-Adrenergic Receptor Agonist: B3465

  2026-08-10

  Explore how 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine can support α2-adrenergic receptor signaling research. This article translates osteosarcoma immunology findings into a practical assay framework for separating direct tumor effects from immune-mediated responses.

• Caspase-3 Colorimetric Assay Kit: Practical Guide

  2026-08-09

  The Caspase-3 Colorimetric Assay Kit (SKU K2008) provides a lysate- or extract-based method for measuring DEVD-dependent caspase-3 activity through p-nitroaniline release. It is appropriate for controlled apoptosis assays and comparative caspase activity measurement, but it should not be treated as a live-cell imaging assay or as definitive proof of unique caspase-3 activity without appropriate controls.

• N1-Methylpseudouridine for Better mRNA Assays

  2026-08-08

  N1-Methylpseudouridine is a modified nucleoside for stronger mRNA translation enhancement and reduced innate immune activation. This article presents an assay-centered framework linking modified mRNA design with causal interpretation of CRISPR cancer-metastasis experiments.

• Faropenem sodium in Reliable Cell Assays

  2026-08-07

  A scenario-based guide to using Faropenem sodium (SKU C8712) in infection-linked cell viability, proliferation, and cytotoxicity workflows. It explains stock preparation, controls, MIC-aware dosing, transporter-related interpretation, and practical vendor-selection criteria without treating an antimicrobial as a generic mammalian cell assay reagent.

16305 records 1/1087 page Next 12345 下5页 Last page